P

Inventor

OLSON WILLIAM

US71 patents
⚠️ This page may combine multiple inventors who share the name “OLSON WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

37 patents
US10787501B1Sep 29, 2020

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMA224 citations98
US10975139B1Apr 13, 2021

Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMA15 citations93
US10954289B1Mar 23, 2021

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMA28 citations93
US10633434B2Apr 28, 2020

Anti-C5 antibodies

REGENERON PHARMA20 citations93
US10730944B2Aug 4, 2020

Anti-CD8 antibodies and uses thereof

REGENERON PHARMA30 citations92
US10501526B2Dec 10, 2019

Human antibodies to Ebola virus glycoprotein

REGENERON PHARMA11 citations92
US10081670B2Sep 25, 2018

Human antibodies to Ebola virus glycoprotein

REGENERON PHARMA10 citations92
US9771414B2Sep 26, 2017

Human antibodies to ebola virus glycoprotein

REGENERON PHARMA18 citations92
US11760775B2Sep 19, 2023

Steroids and protein-conjugates thereof

REGENERON PHARMA5 citations86
US10905784B2Feb 2, 2021

Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

REGENERON PHARMA9 citations85
US10736976B2Aug 11, 2020

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

REGENERON PHARMA7 citations84
US10711032B2Jul 14, 2020

Steroids and protein-conjugates thereof

REGENERON PHARMA10 citations84
US10421804B2Sep 24, 2019

Anti-Zika virus antibodies and methods of use

REGENERON PHARMA11 citations84
US11525001B2Dec 13, 2022

Anti-CD8 antibodies and uses thereof

REGENERON PHARMA5 citations82
US11896682B2Feb 13, 2024

Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof

REGENERON PHARMA3 citations74
US12053534B2Aug 6, 2024

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

REGENERON PHARMA2 citations73
US11530255B2Dec 20, 2022

Human antibodies to Ebola virus glycoprotein

REGENERON PHARMA3 citations73
US11117955B2Sep 14, 2021

Anti-Zika virus antibodies and methods of use

REGENERON PHARMA4 citations73
US10829544B2Nov 10, 2020

Human antibodies to Ebola virus glycoprotein

REGENERON PHARMA2 citations73
US11732030B2Aug 22, 2023

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMA2 citations72
US11511001B2Nov 29, 2022

Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

REGENERON PHARMA3 citations72
US11492392B2Nov 8, 2022

Polynucleotides encoding anti-C5 antibodies

REGENERON PHARMA1 citations72
US11479602B2Oct 25, 2022

Methods of treating C5-associated diseases comprising administering anti-C5 antibodies

REGENERON PHARMA1 citations72
US10844137B2Nov 24, 2020

Anti-CTLA-4 antibodies and uses thereof

REGENERON PHARMA2 citations72
US12077587B2Sep 3, 2024

Anti-CD8 antibodies and uses thereof

REGENERON PHARMA2 citations71
US11787867B2Oct 17, 2023

Anti-GITR antibodies and uses thereof

REGENERON PHARMA2 citations71
US10940211B2Mar 9, 2021

Human antibodies to S. aureus hemolysin A toxin

REGENERON PHARMA1 citations71
US10463748B2Nov 5, 2019

Human antibodies to S. aureus Hemolysin A toxin

REGENERON PHARMA1 citations71
US10806780B2Oct 20, 2020

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

REGENERON PHARMA4 citations70
US11453714B2Sep 27, 2022

Human antibodies to influenza hemagglutinin

REGENERON PHARMA1 citations69
US10689436B2Jun 23, 2020

Human antibodies to influenza hemagglutinin

REGENERON PHARMA1 citations69
US10392432B2Aug 27, 2019

Human antibodies to influenza hemagglutinin

REGENERON PHARMA1 citations69
US12589101B2Mar 31, 2026

Cyclodextrin protein drug conjugates

REGENERON PHARMA0 citations63
US12377159B2Aug 5, 2025

Steroids and protein-conjugates thereof

REGENERON PHARMA0 citations63
US12564651B2Mar 3, 2026

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

REGENERON PHARMA0 citations62
US12251440B2Mar 18, 2025

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

REGENERON PHARMA0 citations62
US12152067B2Nov 26, 2024

Human antibodies to ebola virus glycoprotein

REGENERON PHARMA0 citations62

MOTOROLA INC

3 patents

HILL ROM CO INC

2 patents

ORTHO MCNEIL PHARM INC

2 patents

(unassigned)

1 patent

ILLINOIS TOOL WORKS

1 patent

REGENERAN PHARMACEUTICALS INC

1 patent

HILL ROM SERVICES INC

1 patent

DYNAMIC SEALS INC

1 patent

DRAEGER MEDICAL INFANT CARE IN

1 patent

Showing the top 50 of 71 patents by PatentIndex Score.